Chief Commercial Officer @ (November 2025 - April 2026)
Chief Business Officer @ (September 2024 - November 2025)
Chief Strategy Officer @ (March 2018 - September 2024)
Board Member @ (March 2018 - Present)
Executive Director @ (April 2007 - March 2018)
Board Member @ Acumen Health Holdings (May 2018 - August 2021)
Columnist @ Nutraceuticals World Magazine (September 1999 - December 2012)
Manager, Business Development @ (August 2004 - April 2007)
Senior Consultant @ Health Strategy Consulting (January 1999 - January 2002)
Senior Consultant @ (January 1999 - January 2002)
Adam Ismail Education
IESE Business School
MBA (Finance, Management)
2002-2004
Questrom School of Business, Boston University
BSBA (Finance, Organizational Behavior)
1995-1999
Adam Ismail Skills
Strategic Planning
Business Strategy
New Business Development
Marketing Strategy
Product Development
Business Development
Management
International Business
Strategic Partnerships
Food
Strategy
Marketing
Nutrition
Public Speaking
Mergers & Acquisitions
Cross-functional Team Leadership
Brand Management
Sales Management
Negotiation
Market Research
Competitive Analysis
Marketing Communications
Business Planning
Market Analysis
Marketing Management
Product Marketing
Start-ups
Entrepreneurship
Market Planning
Leadership
Girardin Logement Social
Cross Functional Team
Fip Isf
Start Ups
Cross Functional Team Leadership
Mergers and Acquisitions
Adam Ismail Summary
Adam Ismail, based in Salt Lake City, UT, US, is currently a Interim co-CEO and Chief Commercial Officer at KD Pharma Group. Adam Ismail brings experience from previous roles at KD Pharma Group and Global Organization for EPA and DHA Omega-3s. Adam Ismail holds a 2002 - 2004 MBA in Finance, Management @ IESE Business School. With a robust skill set that includes Strategic Planning, Business Strategy, New Business Development, Marketing Strategy, Product Development and more. Adam Ismail has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Adam Ismail?
Find contact details for 700 million professionals.